Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Ozone Decreases Biomarkers of Inflamation (C-Reactive Protein and Erytrocyte Sedimentation Rate) and Improves Pain, Function and Quality of Life in Knee Osteoarthrtitis Patients: A Before-and-After Study and Review of the Literature

Marcos Edgar Fernandez-Cuadros 1 , 2 , * , Olga Susana Perez-Moro 1 , Maria Jesus Albaladejo-Florin 1 and Ruben Algarra-Lopez 1
Authors Information
1 Hospital Universitario Santa Cristina, Madrid, Spain
2 Fundacion Hospital General Santisima Trinidad, Salamanca, Spain
Article information
  • Middle East Journal of Rehabilitation and Health: April 2018, 5 (2); e64507
  • Published Online: April 17, 2018
  • Article Type: Research Article
  • Received: January 5, 2018
  • Revised: February 19, 2018
  • Accepted: February 21, 2018
  • DOI: 10.5812/mejrh.64507

To Cite: Fernandez-Cuadros M E, Perez-Moro O S, Albaladejo-Florin M J, Algarra-Lopez R. Ozone Decreases Biomarkers of Inflamation (C-Reactive Protein and Erytrocyte Sedimentation Rate) and Improves Pain, Function and Quality of Life in Knee Osteoarthrtitis Patients: A Before-and-After Study and Review of the Literature, Middle East J Rehabil Health Stud. 2018 ; 5(2):e64507. doi: 10.5812/mejrh.64507.

Copyright © 2018, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Fernandez-Cuadros ME, Perez-Moro OS, Albaladejo-Florin MJ. Ozone Fundamentals and effectiveness on knee pain: Chondromalacia and knee Osteoarthritis. Germany: Lambert Academic Publishing; 2016.
  • 2. Fernández Cuadros ME, Pérez Moro OS, Albaladejo Florin MJ, Mirón Canelo JA. Ozone improves pain, function and quality of life in patients with knee osteoarthritis: A prospective quasi-experimental before-after study. Middle East J Rehabil Health. 2016;4(1). doi: 10.17795/mejrh-41821.
  • 3. Fernandez-Cuadros ME, Perez-Moro OS, Albaladejo-Florin MJ. Knee osteoarthritis: Condroprotector action and symptomatic effect of ozone on pain, function, quality of life, minimal joint space and knee arthroplasty delay. Middle East J Rehabil Health. 2017;4(1).
  • 4. Fernández-Cuadros ME. Análisis de la calidad de vida en pacientes con prótesis total de rodilla. Spain: Universidad de Salamanca; 2013.
  • 5. Fernandez-Cuadros ME, Perez-Moro OS, Miron-Canelo JA. Could Ozone be used as a feasible future treatment in osteoarthritis of the knee? Divers Equal Health Care. 2016;13(3):232-9.
  • 6. Mobasheri A, Bay-Jensen AC, van Spil WE, Larkin J, Levesque MC. Osteoarthritis Year in Review 2016: biomarkers (biochemical markers). Osteoarthritis Cartilage. 2017;25(2):199-208. doi: 10.1016/j.joca.2016.12.016. [PubMed: 28099838].
  • 7. Vaillant JD, Fraga A, Diaz MT, Mallok A, Viebahn-Hansler R, Fahmy Z, et al. Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats. Eur J Pharmacol. 2013;714(1-3):318-24. doi: 10.1016/j.ejphar.2013.07.034. [PubMed: 23911887].
  • 8. Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyere O, Chapurlat R, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis. 2013;72(11):1756-63. doi: 10.1136/annrheumdis-2013-203726. [PubMed: 23897772].
  • 9. Rubén Daniel Arellano PV, Jesús Rafael AA, Morán-Martínez J, García-Marín A, Guzmán D, Lizette Sarai AM. Biochemical Markers in Osteoarthritis. Int J Bone Rheumatol Res. 2015;2(2):11-7. doi: 10.19070/2470-4520-150003.
  • 10. Weinstein AM, Rome BN, Reichmann WM, Collins JE, Burbine SA, Thornhill TS, et al. Estimating the burden of total knee replacement in the United States. J Bone Joint Surg Am. 2013;95(5):385-92. doi: 10.2106/JBJS.L.00206. [PubMed: 23344005].
  • 11. Alberto Alexandre EB, Andrea Alexandre EI. Disc herniation and knee arthritis as chronic oxidative stress diseases: The therapeutic role of Oxygen Ozone therapy. J Arthritis. 2015;4(3). doi: 10.4172/2167-7921.1000161.
  • 12. Möller I, Gharbi M, Martínez H, Herrero M, Vergés J, Henrotin Y. Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: How to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients. Osteoarthr Cartil. 2016;24:77. doi: 10.1016/j.joca.2016.01.165.
  • 13. García FJB. Manual SER de las enfermedades reumáticas. Médica Panamericana; 2004.
  • 14. Saxne T, Lindell M, Mansson B, Petersson IF, Heinegard D. Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology (Oxford). 2003;42(7):903-4. doi: 10.1093/rheumatology/keg214. [PubMed: 12826709].
  • 15. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage. 2002;10(8):595-601. doi: 10.1053/joca.2002.0800. [PubMed: 12479380].
  • 16. Malathi R. Raised serum IL 6 and CRP in radiographic knee osteoarthritis in Eastern India. J Med Sci Clin Res. 2017;5(5):21687-92. doi: 10.18535/jmscr/v5i5.73.
  • 17. Fernandez-Cuadros ME, Pérez-Moro OS, Miron-Canelo JA. Knee osteoarthritis: Impact on quality of life and effectiveness of total knee arthroplasty. Divers Equal Health Care. 2016;13(4):278-83.
  • 18. Fernandez-Cuadros ME, Perez-Moro OS, Miron-Canelo JA. Age and comorbidities affect quality of life in patients with osteoarthrtitis and knee replacement. Middle East J Rehabil Health. 2016;3(4). doi: 10.17795/mejrh-40247.
  • 19. Mawsouf MN, El-Sawalhi MM, Darwish HA, Shaheen AA, Martínez-Sánchez G, Re L. Effect of ozone therapy on redox status in experimentally induced arthritis. Revista Espa-ola de Ozonoterapia. 2012;1(1):32-4.
  • 20. Chang JD, Lu HS, Chang YF, Wang D. Ameliorative effect of ozone on cytokine production in mice injected with human rheumatoid arthritis synovial fibroblast cells. Rheumatol Int. 2005;26(2):142-51. doi: 10.1007/s00296-004-0526-1. [PubMed: 15570426].
  • 21. Zhu Z, Jin X, Wang B, Wluka A, Antony B, Laslett LL, et al. Cross-Sectional and Longitudinal Associations Between Serum Levels of High-Sensitivity C-Reactive Protein, Knee Bone Marrow Lesions, and Knee Pain in Patients With Knee Osteoarthritis. Arthritis Care Res (Hoboken). 2016;68(10):1471-7. doi: 10.1002/acr.22834. [PubMed: 26748954].
  • 22. Perez-Moro O, Albaladejo-Florín M, Entrambasaguas-Estepa B, Fernandez-Cuadros M. Effectivenness of PRP on pain, function and quality of life in chondromalacia and patellofemoral pain syndrome: A pretest-postest analysis. Nov Tech Arthritis Bone Res. 2017;1(1).
  • 23. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833-40. [PubMed: 3068365].
  • 24. Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage. 2015;23(8):1233-41. doi: 10.1016/j.joca.2015.03.036. [PubMed: 25865392].
  • 25. Rainbow R, Ren W, Zeng L. Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches. Arthritis. 2012;2012:741582. doi: 10.1155/2012/741582. [PubMed: 22745906].
  • 26. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249-57. doi: 10.1016/j.bone.2012.02.012. [PubMed: 22387238].
  • 27. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16-21. doi: 10.1016/j.joca.2012.11.012. [PubMed: 23194896].
  • 28. Nguyen LT, Sharma AR, Chakraborty C, Saibaba B, Ahn ME, Lee SS. Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis. Int J Mol Sci. 2017;18(3). doi: 10.3390/ijms18030601. [PubMed: 28287489].
  • 29. Griffin TM, Huebner JL, Kraus VB, Yan Z, Guilak F. Induction of osteoarthritis and metabolic inflammation by a very high-fat diet in mice: effects of short-term exercise. Arthritis Rheum. 2012;64(2):443-53. doi: 10.1002/art.33332. [PubMed: 21953366].
  • 30. Muschter D, Gottl C, Vogel M, Grifka J, Straub RH, Grassel S. Reactivity of rat bone marrow-derived macrophages to neurotransmitter stimulation in the context of collagen II-induced arthritis. Arthritis Res Ther. 2015;17:169. doi: 10.1186/s13075-015-0684-4. [PubMed: 26104678].
  • 31. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005;64(9):1263-7. doi: 10.1136/ard.2004.025270. [PubMed: 15731292].
  • 32. Sun AR, Panchal SK, Friis T, Sekar S, Crawford R, Brown L, et al. Obesity-associated metabolic syndrome spontaneously induces infiltration of pro-inflammatory macrophage in synovium and promotes osteoarthritis. PLoS One. 2017;12(8). e0183693. doi: 10.1371/journal.pone.0183693. [PubMed: 28859108].
  • 33. Rousseau J, Garnero P. Biological markers in osteoarthritis. Bone. 2012;51(2):265-77. doi: 10.1016/j.bone.2012.04.001. [PubMed: 22538364].
  • 34. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005;13(5):361-7. doi: 10.1016/j.joca.2005.01.005. [PubMed: 15882559].
  • 35. Smith JW, Martins TB, Gopez E, Johnson T, Hill HR, Rosenberg TD. Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Ther Adv Musculoskelet Dis. 2012;4(5):315-25. doi: 10.1177/1759720X12455959. [PubMed: 23024709].
  • 36. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997;40(4):723-7. doi: 10.1002/1529-0131(199704)40:4<723::AID-ART18>3.0.CO;2-L. [PubMed: 9125256].
  • 37. Pelletier JP, Raynauld JP, Caron J, Mineau F, Abram F, Dorais M, et al. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann Rheum Dis. 2010;69(12):2095-101. doi: 10.1136/ard.2009.122002. [PubMed: 20570834].
  • 38. Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage. 2007;15(5):516-23. doi: 10.1016/j.joca.2006.10.010. [PubMed: 17157039].
  • 39. Jin X, Beguerie JR, Zhang W, Blizzard L, Otahal P, Jones G, et al. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(4):703-10. doi: 10.1136/annrheumdis-2013-204494. [PubMed: 24363360].
  • 40. Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG, Oei EH, Hofman A, Karsdal MA, et al. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Arthritis Res Ther. 2016;18:81. doi: 10.1186/s13075-016-0976-3. [PubMed: 27039382].
  • 41. He Y, Siebuhr AS, Brandt-Hansen NU, Wang J, Su D, Zheng Q, et al. Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation. BMC Musculoskelet Disord. 2014;15:309. doi: 10.1186/1471-2474-15-309. [PubMed: 25245039].
  • 42. Sanchez-Ramirez DC, van der Leeden M, van der Esch M, Gerritsen M, Roorda LD, Verschueren S, et al. Association of serum C-reactive protein and erythrocyte sedimentation rate with muscle strength in patients with knee osteoarthritis. Rheumatology (Oxford). 2013;52(4):727-32. doi: 10.1093/rheumatology/kes366. [PubMed: 23275388].
  • 43. Stannus OP, Jones G, Blizzard L, Cicuttini FM, Ding C. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann Rheum Dis. 2013;72(4):535-40. doi: 10.1136/annrheumdis-2011-201047. [PubMed: 22580582].
  • 44. Arendt-Nielsen L, Eskehave TN, Egsgaard LL, Petersen KK, Graven-Nielsen T, Hoeck HC, et al. Association between experimental pain biomarkers and serologic markers in patients with different degrees of painful knee osteoarthritis. Arthritis Rheumatol. 2014;66(12):3317-26. doi: 10.1002/art.38856. [PubMed: 25168637].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments